Stem Cells Associated with Macroporous Bioceramics for Long Bone Repair: 6- to 7-Year Outcome of a Pilot Clinical Study
Abstract
Extensive bone loss is still a major problem in orthopedics. A number of different therapeutic approaches have been developed and proposed, but so far none have proven to be fully satisfactory. We used a new tissue engineering approach to treat four patients with large bone diaphysis defects and poor therapeutic alternatives. To obtain implantable three-dimensional (3D) living constructs, cells isolated from the patients' bone marrow stroma were expanded in culture and seeded onto porous hydroxyapatite (HA) ceramic scaffolds designed to match the bone deficit in terms of size and shape. During the surgical session, an Ilizarov apparatus or a monoaxial external fixator was positioned on the patient's affected limb and the ceramic cylinder seeded with cells was placed in the bone defect. Patients were evaluated at different postsurgery time intervals by conventional radiographs and computed tomography (CT) scans. In one patient, an angiographic evaluation was performed at 6.5 years follow-up. In this study we analyze the long-term outcome of these patients following therapy. No major complications occurred in the early or late postoperative periods, nor were major complaints reported by the patients. No signs of pain, swelling, or infection were observed at the implantation site. Complete fusion between the implant and the host bone occurred 5 to 7 months after surgery. In all patients at the last follow-up (6 to 7 years postsurgery in patients 1 to 3), a good integration of the implants was maintained. No late fractures in the implant zone were observed. The present study shows the long-term durability of bone regeneration achieved by a bone engineering approach. We consider the obtained results very promising and propose the use of culture-expanded osteoprogenitor cells in conjunction with porous bioceramics as a real and significant improvement in the repair of critical-sized long bone defects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Culture-expanded BM-MSCs on ceramic biomaterials result in complete fusion of bone segmental defects upon transplantation in vivo with enduring results at follow-up 6-7 years post operatively.
“Specifically, culture-expanded BM-MSCs on ceramic biomaterials result in the complete fusion of bone segmental defects upon transplantation in vivo with enduring results at follow-up 6–7 years post operatively [39,96].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [96]
Cited by
Sorted by citations
Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects
Perez, J. R., Kouroupis, D., Li, D. J., Best, T. M., Kaplan, L., & Correa, D. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00105 · Cited by 390 · see citing works
Scaffolds based bone tissue engineering: the role of chitosan
Costa-Pinto, A. R., Reis, R. L., & Neves, N. M. (2011) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2010.0704 · Cited by 355 · see citing works
Mesenchymal stem cells: Amazing remedies for bone and cartilage defects
Kangari, P., Talaei-Khozani, T., Razeghian-Jahromi, I., & Razmkhah, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02001-1 · Cited by 286 · see citing works
Prospective Review of Mesenchymal Stem Cells Differentiation into Osteoblasts
Garg, P., Mazur, M. M., Buck, A. C., Wandtke, M. E., Liu, J., & Ebraheim, N. A. (2017) · Orthopaedic Surgery · doi:10.1111/os.12304 · Cited by 190 · see citing works
Liebergall, M., Schroeder, J., Mosheiff, R., Gazit, Z., Yoram, Z., Rasooly, L., Daskal, A., Khoury, A., Weil, Y., & Beyth, S. (2013) · Molecular Therapy · doi:10.1038/mt.2013.109 · Cited by 134 · see citing works
Hildebrandt, C., Büth, H., Cho, S., Impidjati, & Thielecke, H. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.007 · Cited by 95 · see citing works
Seebach, E., Freischmidt, H., Holschbach, J., Fellenberg, J., & Richter, W. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.07.017 · Cited by 92 · see citing works
Eder, C., Schmidt-Bleek, K., Geissler, S., Sass, F. A., Maleitzke, T., Pumberger, M., Perka, C., Duda, G. N., & Winkler, T. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05428-0 · Cited by 33 · see citing works
Late sarcoma development after curettage and bone grafting of benign bone tumors
Picci, P., Sieberova, G., Alberghini, M., Balladelli, A., Vanel, D., Hogendoorn, P. C. W., & Mercuri, M. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.06.053 · Cited by 28 · see citing works
Yang, X.-J., Wang, F.-Q., Lu, C.-B., Zou, J.-W., Hu, J.-B., Yang, Z., Sang, H.-X., & Zhang, Y. (2020) · Biomedical Materials · doi:10.1088/1748-605x/ab8720 · Cited by 28 · see citing works
Baron, M., Drohat, P., Crawford, B., Hornicek, F. J., Best, T. M., & Kouroupis, D. (2023) · Bioengineering · doi:10.3390/bioengineering10101187 · Cited by 19 · see citing works
Giannotti, S., Trombi, L., Bottai, V., Ghilardi, M., D'Alessandro, D., Danti, S., Dell'Osso, G., Guido, G., & Petrini, M. (2013) · PLoS ONE · doi:10.1371/annotation/e4403abb-b80e-43c5-be74-1bdb2c899d1c · Cited by 12 · see citing works
- Authors
- Marcacci, M., Kon, E., Moukhachev, V., Lavroukov, A., Kutepov, S., Quarto, R., Mastrogiacomo, M., & Cancedda, R.
- Affiliations
- Istituto Ortopedico Rizzoli (IT)
- Ural Orthopedic Research Institute, Ekaterinburg, Russia.
- Ural State Medical Academy, Ekaterinburg, Russia.
- University of Genoa (IT)
- Venue
- Tissue Engineering
- Publisher
- SAGE Publications
- Published
- 2007-05
- Volume
- 13
- Issue
- 5
- Pages
- 947-955
- ISSN
- 1076-3279 (ISSN-L)
- 1557-8690
- OpenAlex
- W2021164682
- Cited by
- 589
- References
- 0
- Citations by year
- 2026: 11 · 2025: 5 · 2024: 12 · 2023: 13 · 2022: 13 · 2021: 26 · 2020: 24 · 2019: 32 · 2018: 36 · 2017: 32 · 2016: 37 · 2015: 39 · 2014: 35 · 2013: 68 · 2012: 63
- FWCI
- 21.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Tissue Engineering (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- bone tissue engineering, mesenchymal stem cells, osteoprogenitor cells, critical-size bone defect, Ilizarov external fixator, external fixation, bone regeneration, bone fusion
- MeSH terms
- Adolescent, Adult, Bioprosthesis, Bone Marrow Cells, Bone Resorption, Ceramics, Female, Follow-Up Studies, Humans, Male, Pilot Projects, Radiography, Stem Cells, Porosity, Treatment Outcome, Stromal Cells, Durapatite, Bone Substitutes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review